Updates are available Correction dated 2022-10-10
Click to view Correction: https://doi.org/10.1038/s41391-022-00596-5
Updates are available Correction dated 2022-07-11
Click to view Correction: https://doi.org/10.1038/s41391-022-00568-9
-
Authors
Shao, Yu-Hsuan Joni https://orcid.org/0000-0002-0757-1901
Hong, Jian-Hua
Chen, Chun-Kai
Huang, Chao-Yuan
-
Funding
Funding for this research was provided by:
FERRING Pharmaceuticals Ltd.
- License Information
-
More Information
Article History
Received: 28 January 2022
Revised: 16 May 2022
Accepted: 25 May 2022
First Online: 3 June 2022
Change Date: 10 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-022-00596-5
Change Date: 11 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-022-00568-9
Competing interests
: All authors declare no competing interests.
: The study was conducted according to the Declaration of Helsinki and the International Society for Pharmacoepidemiology Guidelines for Good Pharmacoepidemiology Practices. It was carried out retrospectively using an anonymized database. This study was reviewed and approved by the Institutional Review Board of Taipei Medical University (TMU-JIRB no. 201502042). All authors had full access to the data and take responsibility for data integrity and analysis.
